New challenges for surgical treatment of hepatocellular carcinomaWU Meng-chao, ZHOU Wei-ping, PAN Ze-ya257-259,263
Hotspots and strategies of the prevention and treatment of hepatocellular carcinomaBAI Wen-lin, YANG Yong-ping260-263
Brief introduction to 2012 EASL-EORTC Clinical Practice Guidelines on the management of hepatocellular carcinomaQU Jian-hui, SU Shu-hui264-268
Effect of matrix metalloproteinase inhibitor LY52 on the invasion ability of hepatocellular carcinoma cell line HepG2.2.15ZHAO Xin, DONG Lei, HONG Zhi-xian, ZHANG Ke-ming, XIAO Zhao-hui, ZHANG Shao-geng, TANG Wei269-272
HBV DNA Level and the expression of HBsAg/HBcAg in patients with HBV-related hepatocellular carcinomaQU Jian-hui, BAI Wen-lin, CHANG Xiu-juan, LOU Min, LIU Ze, WANG Chun-ping, CHEN Yan, YANG Yong-ping273-275
Relationship between HBV X protein and angiopoietin-2 and hepatitis B-related hepatocellular carcinomaHE Yun, NIU Zi-chang, LIANG Hong-xia, SI Hui-yuan276-277,291
Application of magnetic resonance imaging to the diagnosis of hepatic adenomasCHANG Xiu-juan, WANG Chun-ping, LU Yin-ying, LIU Ze, QU Jian-hui, ZENG Zhen, LOU Min, SU Shu-hui, XU Gui-lin, GAO Xu-dong, WANG Hong, YANG Yong-ping278-280
MRI evaluation of the early effect of argon-helium cryoablation therapy for patients with hepatocellular carcinomaDONG Jing-hui, MA Wei, LIU Chang-chun, REN Hong-wei, GAO Yuan-zhi, XIE Hui, AN Wei-min281-283
Prevention and avoidance of the risk of color Doppler ultrasound-guided liver biopsyFENG Song, LI Zhi-yan, ZHOU Yan-xian, FENG Hui, LIU Yang, TANG Yu, DONG Xiao-yu284-286
Increased incidence of hepatocellular carcinoma due to antiviral drug resistance in patients with hepatitis B-related decompensated cirrhosisLI Lei, LIU Wei, CHEN Yu-han, LI Peng, WEI Fei-li, FAN Chun-lei, DONG Pei-ling, LI Bing, CHEN De-xi, DING Hui-guo287-291